Structure–Activity Relationship and Stage-Dependent Inhibition of Adipogenesis by Curcuminoid Derivatives in 3T3-L1 Cells
Authors:
- Suzuna ArakiSASuzuna Araki
- Yumi UedaYUYumi Ueda
- Hinako AyabeHAHinako Ayabe
- Rio OtsukaRORio Otsuka
- Kengo KohamaKKKengo Kohama
- Kouta MaenishiKMKouta Maenishi
- Changsun ChoiChangsun Choi
- Sung-Kwon MoonSung-Kwon Moon
- Toshiya MasudaTMToshiya Masuda
- Miwako DeguchiMDMiwako Deguchi
- Shigeru SaekiSSShigeru Saeki
- DongHo KimDKDongHo Kim
Open Access
Abstract
Background/Objectives: To address the limitations of natural curcumin, this study focuses on the functional evaluation of structurally optimized derivatives. We aimed to elucidate structure–activity relationships (SAR) and the stage-specific molecular mechanisms of adipogenesis inhibition using an in vitro cellular assay. Methods: Four novel curcuminoids were synthesized and evaluated in 3T3-L1 preadipocytes against natural curcumin (Curcuminoid I). Efficacy and mechanisms were assessed via cell viability assays, quantitative Oil Red O staining, and time-dependent transcriptional profiling (qPCR/Western blotting) of the KLF family and master regulators. Results: SAR analysis identified Curcuminoid III (symmetric 3,5-dimethoxy-4-hydroxy) as the most potent and safe candidate, whereas Curcuminoid IV exhibited cytotoxicity. Time-course analysis revealed a distinct step-wise inhibition mechanism wherein Curcuminoid III significantly upregulated the differentiation repressor KLF2 at the immediate-early phase. This rapid modulation effectively prevented the subsequent induction of pro-adipogenic factors, including KLF9, KLF15, PPARγ, and C/EBPα, in the mid-stage (3–5 d). Consequently, the expression of the maturation marker aP2 was robustly suppressed by the late stage (5–7 d). Conclusions: The symmetric 3,5-dimethoxy-4-hydroxy substitution pattern appears to confer strong anti-adipogenic activity to Curcuminoid III. Early modulation of the KLF2–PPARγ axis at the onset of differentiation may initiate a cascading inhibitory effect throughout the adipogenic program. These findings highlight the potential of structurally optimized plant-derived bioactive compounds as regulators of metabolic cell fate.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (23650487)
- Japan Society for the Promotion of Science (19K11646)
This publication has 53 references indexed in Scilit:
- A study on the association between antiobesity effects of lactoferrin and genetic variationsJournal of Functional Foods, 2023
- Assay validation for the assessment of adipogenesis of multipotential stromal cells—a direct comparison of four different methodsCytotherapy, 2013
- Bistability, Bifurcations, and Waddington's Epigenetic LandscapeCurrent Biology, 2012
- Protocol for effective differentiation of 3T3-L1 cells to adipocytesAnalytical Biochemistry, 2012
- PPARγ in adipocyte differentiation and metabolism – Novel insights from genome‐wide studiesFEBS Letters, 2010
- Developmental Origin of Fat: Tracking Obesity to Its SourceCell, 2007
- Transcriptional control of adipocyte formationCell Metabolism, 2006
- Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiationCell Metabolism, 2005
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Sublines of mouse 3T3 cells that accumulate lipidCell, 1974